Lv1
70 积分 2023-01-23 加入
IBI362 (LY3305677), a weekly-dose GLP-1 and glucagon receptor dual agonist, in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple ascending dose phase 1b study
1天前
已关闭
A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity
1天前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
1天前
已完结
Early detection of multiple cancer types using multidimensional cell-free DNA fragmentomics
1个月前
已完结
PD-L1 and the dawn of modern cancer immunotherapy
1个月前
已完结
基于社区的阿尔茨海默病三级综合防治中国专家共识(2025版)
2个月前
已完结
社区轻度认知功能障碍数字化筛查专家共识（2025版）
2个月前
已完结
Use of computer-assisted detection (CADe) colonoscopy in colorectal cancer screening and surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement
3个月前
已完结
老年心肺功能减退全流程健康管理方案专家共识
3个月前
已完结
Direct-to-Consumer Genetic Testing for Cardiovascular Disease: A Scientific Statement From the American Heart Association
3个月前
已完结
皖公网安备34019202002308
